Related Experiment Videos

bcl-2 acts early to restrict Semliki Forest virus replication and delays virus-induced programmed cell death

M F Scallan1, T E Allsopp, J K Fazakerley

  • 1Department of Veterinary Pathology, University of Edinburgh, United Kingdom.

Journal of Virology
|February 1, 1997
PubMed

Insights

Semliki Forest virus (SFV) infection induces apoptosis in cancer cells. Overexpressing bcl-2 protein inhibits SFV replication and cell death, leading to chronic infections.

Area of Science:

  • Virology
  • Cell Biology
  • Cancer Research

Background:

  • Semliki Forest virus (SFV) infection in rat prostatic adenocarcinoma cells induces apoptosis.
  • Apoptosis occurs faster with the neurovirulent L10 SFV strain compared to the avirulent A7 strain.

Purpose of the Study:

  • To investigate the role of the antiapoptotic proto-oncogene bcl-2 in SFV-induced apoptosis.
  • To determine the effect of bcl-2 on SFV replication and the establishment of chronic infections.

Main Methods:

  • Morphological assessment and TUNEL assay for apoptosis.
  • Overexpression of bcl-2 in infected cells.
  • In situ hybridization for viral RNA and immunostaining for viral protein.
  • Double-immunofluorescent labeling for bcl-2 and viral glycoproteins.

Main Results:

  • bcl-2 overexpression allowed cell survival and drastically reduced productive infection.
  • bcl-2 inhibited SFV replication at an early stage (entry, pretranscriptional events, or transcription).
  • The early replication block was overcome over time, leading to apoptosis in bcl-2-expressing cells.
  • bcl-2 expression led to the establishment of chronically infected, passaged cell lines.

Conclusions:

  • bcl-2 plays a critical role in regulating SFV-induced apoptosis and viral replication.
  • Modulating the balance between cell death and division via bcl-2 can establish persistent viral infections.

Related Concept Videos